INTRODUCTION
Medulloblastoma is the most common malignant brain tumor of childhood. Surgery alone is not suffi cient to eradicate this tumor, and both radiotherapy and chemotherapy are considered ineffi cient treatments, mostly due to the high vulnerability of young patients to the toxic effects of antimitotic treatments. The restricted incidence of medulloblastoma during childhood relates to the peculiar ontogeny of the cerebellum, which begins early during embryonic development, reaching its fi nal maturation only after birth
ABSTRACT
Medulloblastoma arises from mutations occurring in stem/progenitor cells located in restricted hindbrain territories. Here we report that the mouse postnatal ventricular zone lining the IV ventricle also harbors bona fi de stem cells that, remarkably, share the same molecular profi le with cerebellar white matter-derived neural stem cells (NSC). To identify novel molecular mediators involved in medulloblastomagenesis, we compared these distinct postnatal hindbrain-derived NSC populations, which are potentially tumor initiating, with murine compound Ptch/p53 mutant medulloblastoma cancer stem cells (CSC) that faithfully phenocopy the different variants of human medulloblastoma in vivo. Transcriptome analysis of both hindbrain NSCs and medulloblastoma CSCs resulted in the generation of well-defi ned gene signatures, each reminiscent of a specifi c human medulloblastoma molecular subclass. Most interestingly, medulloblastoma CSCs upregulated developmentally related genes, such as Ebfs, that were shown to be highly expressed in human medulloblastomas and play a pivotal role in experimental medulloblastomagenesis. These data indicate that gene expression analysis of medulloblastoma CSCs holds great promise not only for understanding functional differences between distinct CSC populations but also for identifying meaningful signatures that might stratify medulloblastoma patients beyond histopathologic staging.
SIGNIFICANCE:
The functional and molecular comparison between the cell progenitor lineages from which medulloblastoma is thought to arise and medulloblastoma CSCs might lead to the identifi cation of novel, potentially relevant mediators of medulloblastomagenesis. Our fi ndings provide a rationale for the exploitation of mouse CSCs as a valuable preclinical model for human medulloblastoma, both for the defi nition of CSC-associated gene signatures with predictive mean and for the identifi cation of therapeutically targetable genes. Cancer Discov; 2 (6) ; 554-68. ©2012 AACR.
(1). This delayed maturation results in a prolonged formative postnatal period, characterized by increased susceptibility to tumor formation. Whereas the majority of patients are diagnosed with medulloblastoma at a very early age, suggesting that medulloblastomas initiate from mutations occurring during embryonic development in hindbrain germinative regions (2, 3) , 20% of medulloblastoma patients develop medulloblastomas in late adolescence or early adulthood, indicating that medulloblastoma might also arise postnatally.
Different subsets of neural precursors persist postnatally within the hindbrain and, as such, are potentially involved in medulloblastomagenesis. In the mouse, the best characterized progenitor population comprises the so-called granule cell progenitors (GCP) of the external granular layer (EGL), which are characterized by a peak of proliferation at postnatal day (P) 7, followed by progressive decline and exhaustion within the third postnatal week. GCPs proliferate robustly in vivo and in vitro in response to Sonic Hedgehog (Shh), and their deregulated postnatal proliferation has been causatively implicated in the development of the desmoplastic medulloblastoma variant, characterized by alterations in the Shh pathway (2) . However, GCPs do not satisfy the requirements for stemness, as they are characterized by limited self-renewal and lack of multipotency. On the contrary, the other population of transiently neurogenic progenitors identifi ed within the cerebellum white matter during the same postnatal window of EGL GCPs does contain bona fi de neural stem cells (NSC) that can be cultured in vitro in the presence of epidermal growth factor (EGF) and fi broblast growth factor-2 (FGF-2) and display typical features of NSCs, such as selfrenewal and in vitro/in vivo multipotency (4) (5) (6) .
Of note, a third subset of hindbrain neural progenitors has been retrieved in proximity of the IV ventricle (IVv), around which the cerebellum proper develops. IVv-derived progenitors are endowed with persistent neurogenic activity throughout adulthood (7, 8) . However, the establishment of long-term self-renewing NSC lines from the IVv has never been reported. Interestingly, oncogenic transformation of progenitors located in the dorsal brainstem, as IVv NSCs are, has been associated with the development of a subtype of the "classic" medulloblastoma variant, whose main molecular feature is activation of the WNT pathway (3) .
Cancer stem cells (CSC) are responsible for tumor growth and maintenance and, being resistant to standard therapies, are likely involved in tumor relapse. CSCs can be isolated from brain tumors and cultured in vitro long term in the presence of EGF and FGF-2. By this method, putative CSC lines have been established from desmoplastic medulloblastomas developing in Ptch +/− mice (9), alone or in combination with p53 loss (10) . Medulloblastoma CSCs, characterized by expression of the CSC marker CD15 (9, 11) , display the essential requirement for a CSC, that is, the capability to generate new tumors, which closely mimic the human disease in terms of in vivo growth and phenotype.
To identify novel molecular determinants to be pursued as diagnostic markers and/or therapeutic targets in medulloblastoma CSCs, we set out to establish long-term expanding postnatal NSC lines from the IVv as well as from the cerebellum white matter and to compare them with medulloblastoma CSCs. IVv NSCs were capable of differentiating into the 3 main lineages of the central nervous system (CNS) both in vitro and in vivo, thus fulfi lling the requirements to qualify as bona fi de NSCs. By applying the same culture conditions to mouse medulloblastomas derived from Ptch +/− mutants with or without the concurrent loss of p53, we isolated several medulloblastoma CSC lines endowed with self-renewal, multipotency, and different tumorigenic potential. When subjected to microarray-based gene expression profi ling, normal cerebellum white matter and IVv-derived SCs as well as medulloblastoma CSCs were characterized by distinctive gene signatures that hold predictive potential when tested against human data sets as previously shown for other stem cell types (12, 13) . Most importantly, some of the genes upregulated in medulloblastoma CSCs were also expressed in human medulloblastoma and play a relevant role in the control of medulloblastomagenesis, thus validating medulloblastoma CSCs as a valuable preclinical model for medulloblastoma.
RESULTS

Long-term Expanding NSCs Can Be Isolated from the Postnatal Ventricular Zone of the IV Ventricle
The ventricular zone lining the IVv contains mitotically active cells (Fig. 1A) whose proliferation can be reactivated in vivo by infusion of mitogens (14) . To assess whether IVv NSCs might give rise to long-term expanding NSC lines, we cultured the IVv region from the mouse hindbrain at P7, P14, P21, and P30 (Fig. 1B) according to the NeuroSphere Assay. Cerebellum white matter and the subventricular zone lining the 2 lateral ventricles of the forebrain were used as controls.
At P14, P21, and P30, cell lines could be generated only from IVv and subventricular zone, confi rming that sustained proliferation of cerebellum white matter cells ceases by the fi rst postnatal week (5) . However, at P7, long-term expanding cell lines could be established from all 3 regions; therefore, we analyzed NSCs at this time point. Cells were isolated from wild-type (wt), Ptch +/− p53 +/+ and Ptch
mice. Cerebellum white matter and IVv NSCs gave rise to a much lower frequency of primary neurospheres than cells from the subventricular zone, independently of genotype (Fig. 1B) . Clonal NSC lines were established that self-renewed up to 40 subculturing passages in vitro, again independently of genotype and, also, of the region of origin (Fig. 1B) . The 3 regions and the clonal NSC lines derived from them comprised a higher frequency of CD15/SSEA1-IR cells than CD133/Prom1-IR cells (Fig. 1C ). All NSC populations gave rise to neurons, astrocytes, and oligodendrocytes, thus showing full multipotency ( Fig. 1D and Supplementary Table S1A) . However, electrophysiologic analysis of terminally differentiated neurons obtained from region-specifi c NSCs indicated that they were intrinsically different in their electroresponsiveness (Fig. 1E) Fold increase in Emx2 expression in subventricular zone NSCs was obtained with respect to cerebellum NSCs; fold increase in Pax3 expression in cerebellum and IVv NSCs was calculated with respect to subventricular zone NSCs. C, Pax3 protein nuclear expression in cerebellum and IVv NSCs (×200). D, ISH for En2 and Emx2 mRNA on P7 brain tissue (×200). E, immunohistochemistry for Pax3 and FoxG1 (×400). F, medulloblastoma/PNET-like lesions are generated by the coimplantation of GFP-labeled cerebellum/IV NSCs with pancreatic islets under the renal capsule. The tumor generated from cerebellum NSCs (asterisk, ×40, ×100; top) is GFP-IR (bottom left). High-magnifi cation fi elds depict typical rosette-like structures (bottom right panel, ×200 and ×400). Arrows point to grafted pancreatic islets. G, GSEA enrichment plots. Each gene signature was compared with molecular subgroups from a human medulloblastoma data set. The nominal P value and the FDR Q value are indicated below. In silico data were validated in cultured NSCs (Fig. 2B and C) and, most relevantly, in tissue sections comprising the regions of origin ( Fig. 2D and E) . Thus, in vitro cultured region-specifi c NSCs maintained their in vivo regionalization and their positional identity. Most remarkably, NSCs from the IVv, that is, an extracerebellar region, were molecularly indistinguishable from cerebellum white matter-derived NSCs.
Given that many medulloblastomas arise postnatally, we challenged postnatal hindbrain NSCs with a pro-oncogenic stimulus, such as chronic exposure to insulin, to test whether they might act as potential medulloblastoma cells of origin (15) . We transplanted C57BL/6 mice with syngeneic pancreatic islets and GFP-labeled hindbrain NSCs under the kidney capsule. In line with previous studies in which tumor suppressor-deleted postnatal cerebellum white matter NSCs were tumorigenic (6), hindbrain NSCs developed GFP-IR tumors, which were characterized by the presence of rosettelike structures, typical of medulloblastoma/primitive neuroectodermal tumor (PNET) (Fig. 2F) .
To investigate whether the gene signatures distinguishing hindbrain-versus forebrain-derived NSCs were enriched in distinct molecular subtypes of human medulloblastoma, we carried out Gene Set Enrichment Analysis (GSEA) on a publicly available data set (GSE21140), which contained expression data from 103 human medulloblastoma samples (16) . We selected 155 and 142 genes that were upregulated at least 2-fold in hindbrain and forebrain NSCs, respectively. Interestingly, the expression of genes upregulated in cerebellum/ IVv NSCs was more strongly associated with the desmoplastic medulloblastoma subgroup than the subventricular zone gene signature (Fig. 2G , Supplementary Table S2 and Supplementary List S1). Accordingly, the same gene signature was exclusively upregulated in the Shh molecular subgroup, which comprises many desmoplastic medulloblastomas. When the global 297-gene signature was tested against all the medulloblastoma subgroups simultaneously, it again sharply separated the Shh subgroup from the others (Supplementary Fig. S1 ).
Hindbrain-and Forebrain-Derived NSCs Are Shh Pathway Independent
To assess whether the Shh pathway, normally active in GCPs, might be operating also in hindbrain NSCs, we took advantage of the genetic confi guration of the Ptch targeting vector, which contains a sequence encoding a nuclear β-galactosidase (LacZ) and the neomycin resistance gene. If Ptch Fig. S2A ). Primary cells from subventricular zone, cerebellum white matter and IVv self-renewed longterm in the presence of sublethal concentration of G418, thus indicating that cerebellum white matter and IVv NSCs did express Ptch (not shown). However, when wt and Ptch +/− cerebellum white matter and IVv NSCs, cultured for more than 6 subculturing passages (SP), were exposed to 10 μmol/L cyclopamine, a Shh pathway inhibitor, no difference in terms of cell survival and proliferation were observed (Supplementary Fig. S2B ). Accordingly, Shh downstream targets were not expressed in long-term cultured NSC lines, suggesting that they might grow independent of Shh signaling activation ( Supplementary Fig. S2C and D) . To formally prove this concept, we exposed to cyclopamine wt and Ptch +/− subventricular zone, cerebellum white matter and IVv NSC lines starting at SP0 (i.e., primary culture) up to SP14. A remarkable reduction in survival was retrieved in all NSC lines at very early SPs, which was not observed in the same NSCs after additional SPs (Supplementary Fig. S2D ). Accordingly, overexpression of the Shh pathway downstream targets Gli1 and Gli2 as well as downregulation of Gli3 were detected in short-term cultured NSCs, being absent in long-term cultured NSCs ( Supplementary Fig. S2E ). (Fig. 3A) but also in the presence of either growth factor alone (data not shown). Importantly, all cell lines expanded for more than 100 passages, with a doubling time between 2 and 5 days. Medullo-blastoma CSC lines were heterogeneous in terms of growth rate and clonal effi ciency, which was independent from the genotype (Fig. 3A and B Fig. 3C and Supplementary Table S3 ). When exposed to cyclopamine, only a few medulloblastoma CSC lines showed a very modest decrease in survival, which was in line with the low expression of Shh downstream targets in the same cells ( Supplementary Fig. S3A-C) . To test the presumptive independence of medulloblastoma CSCs from Shh signaling for in vitro growth, we generated stable medulloblastoma CSC lines in which Smo was silenced by lentiviral-based short hairpin RNA (shRNA; Supplementary Fig. S3D ). Notably, Smo inhibition, and, as such, Shh pathway inactivation, did not signifi cantly affect medulloblastoma CSC proliferation and survival ( Supplementary Fig. S3D ), thus suggesting that medulloblastoma CSCs might rely on different growth pathways for effi cient growth. were also characterized by LOH for Ptch (Fig. 3D) (Fig. 3D ), was associated with medulloblastomagenesis. Intracranial tumors were detected by MRI after 10 to 12 weeks after transplantation and fully developed within 30 weeks (data not shown). Conversely, subcutaneous tumors were observed as early as at 2 weeks after transplantation and progressed very rapidly. Only NeuroSphere Assay-cultured medulloblastoma CSC lines generated tumors, whereas matched serum-dependent, nonstem cancer cell lines did not.
CSC Lines Can Be Established
Loss of p53 Is
CSC-derived intracranial tumors closely resembled spontaneous Ptch
+/− tumors, although their morphology was slightly more malignant and pleomorphic, with marked atypia and the presence of infi ltrating cellular nests; they also expressed markers typical of human medulloblastoma, such as Tuj1, NeuN, synaptophysin, and GFAP (Fig. 3E) . In a few circumstances, CSC-derived intracranial tumors escaped the site of implantation, through either leptomeningeal or extracranial dissemination. Tumors infi ltrating the meninges expressed lower levels of neuronal and glial markers, whereas extracranial tumors were highly undifferentiated, with signs of pleomorphism and increased malignancy. CSC-derived subcutaneous tumors were the most highly undifferentiated, showing a myxoid and heterogeneous morphology, and containing high numbers of cells expressing the putative CSC marker Sox2. Tuj1-IR cells were also detected, while NeuN-and synaptophysin-IR cells were absent. Thus, the site of tumor formation affects the histologic phenotype of experimental CSC-derived medulloblastomas, with a progressive malignant evolution from lowly malignant intracranial tumors to highly malignant extra-CNS neoplasias.
Molecular Analysis of Medulloblastoma CSCs and Normal NSCs Identifi ed Novel Potential Medulloblastoma Targets
To identify dysregulated genes that may play a role in the pathogenesis of medulloblastoma, we fi rst compared the global gene expression profi les of medulloblastoma CSCs with that of normal NSCs. Unsupervised clustering analysis showed that medulloblastoma CSCs shared many more molecular determinants with hindbrain NSCs than with subventricular zone NSCs. Notably, many more genes were differentially expressed between hindbrain NSCs and Ptch
−/− medulloblastoma CSCs than between hindbrain NSCs and Ptch +/− p53 +/+ medulloblastoma CSCs (Fig. 4A ). These gene expression data were then exploited to generate gene signatures that refl ected the behavior of the distinct populations of medulloblastoma CSCs (Fig. 4B) Fig. S5C ). Thus, human medulloblastomas can be distinguished based on their degree of resemblance to distinct mouse medulloblastoma CSC molecular phenotypes.
Reactivation of Developmentally Regulated Molecular Programs Promotes Medulloblastomagenesis
Early B-cell factors (Ebfs), such as Ebf2 and Ebf3, are expressed in the cerebellum during embryonic development and regulate progenitor cell proliferation and differentiation. Interestingly, they were highly expressed in medulloblastoma CSCs and in their corresponding tumor tissues (Fig. 4C) . Ebf3 expression, in particular, was observed in cycling progenitors located in the mouse EGL as early as P3, peaked at P7, and decreased around P15. Accordingly, Ebf protein expression was retrieved in EGL progenitors and also in cells in the prospective white matter and around the IVv (Fig. 4E ). In line with gene expression data, Ebf protein expression was high in both spontaneous and CSC-derived intracranial tumors, being very low in intrameningeal and subcutaneous CSCderived tumors (Fig. 4E) .
EBF3 expression was detected in silico in human medulloblastomas and in a small fraction of neuroblastomas, whereas it was not retrieved in glial tumors, suggesting a possible association between the expression of the gene and a neuronal tumor phenotype ( Supplementary Fig. S5A and B) . Accordingly, EBF3 transcript and EBF proteins were expressed in human medulloblastomas and not in glioblastoma multiforme (GBM, variants of medulloblastoma. In particular, classic medulloblastomas displayed intense EBF staining in the majority of tumor cells, whereas desmoplastic medulloblastomas showed EBF expression being restricted to desmoplastic portion of the tumor and excluded from the nodular part. Of note, EBF proteins were also strongly expressed in the pleomorphic giant cells found in large-cell anaplastic medulloblastomas.
To address the putative role of Ebf3 in medulloblastomagenesis, we transduced both NSCs and medulloblastoma CSCs with an Ebf3-FLAG lentiviral construct, obtaining efficient expression of Ebf3 transcript and protein ( Fig. 5A and  B) . Mock-and Ebf3-tranduced NSC and CSC lines did not show any difference in proliferation, long-term self-renewal, migration, and apoptosis. However, under proliferative culture conditions (i.e., in the presence of EGF and FGF2), Ebf3-transduced NSC and CSC lines acquired the appearance of cells undergoing differentiation. In fact, whereas normal mock-transduced IVv, cerebellum, and subventricular zone NSCs were almost negative for lineage differentiation markers, Ebf3 overexpressing NSCs showed a consistent increase in the frequency of FLAG-positive cells expressing the neuronal marker Tuj1 and displaying a mature cellular morphology ( Fig. 5C and Supplementary Fig. S7 ). Likewise, Ebf3 overexpressing FLAG-positive CSCs gave rise to Tuj1-IR cells displaying a more mature morphology than Tuj1-IR cells retrieved in mock CSC cultures (Fig. 5C ). Upon differentiation, Ebf3 overexpressing NSC/CSC cultures mostly generated FLAGpositive neuronal-like cells featuring extended processes and well-developed neurites (Fig. 5D) . The frequency of astrocytes and oligodendrocytes was similar between mock-and Ebf3-transduced NSC/CSCs under both proliferative and differentiative conditions (not shown). tumors generated by mock-and Ebf3-transduced CSCs, respectively (×200, ×400). B, expression of GFP, FLAG, and Ebf in subcutaneous tumors generated by mock-and Ebf3-transduced CSCs, respectively (×200, ×400). C, quantitative assessment of tumor development (L51, P < 0.0005; LB, P < 0.005). D, H&E, Tuj1, and GFAP staining in mock-and Ebf3-transduced CSC-derived experimental tumors (×200) Inset in H&E: perivascular rosette. E, the frequency of Ki67 and Sox2-IR cells in Ebf3 overexpressing and mock CSC-derived tumors (P < 0.001). **, P < 0.001; ***, P = 0.0001. F, Ebf2/Ebf3 transcripts and Ebf3 protein were reduced in Ebf-silenced CSCs. G, quantitative assessment of tumor development (L21, P < 0.01). H&E and GFP staining in mock-and Ebf-silenced CSC-derived experimental tumors (×200). H&E, Hematoxylin and eosin.
on June 20, 2017. © 2012 American Association for Cancer Research. cancerdiscovery.aacrjournals.org Downloaded from Mock-and Ebf3-transduced CSC lines were then transplanted intracranially and subcutaneously into adult immune-defi cient mice. In spite of very high effi ciency of Ebf3-FLAG overexpression (Fig. 6A and B) , signifi cant differences in the tumorigenic ability of Ebf3 overexpressing CSCs with respect to mock CSCs were observed only upon subcutaneous transplantation. Indeed, the frequency of cells endogenously expressing Ebf in mock CSC-derived intracranial tumors was very high and comparable with that in Ebf3 expressing tumors. As such, Ebf3 overexpression in CSCs under intracranial transplantation settings was not functionally relevant. On the contrary, given that endogenous Ebf expression in mock CSC-derived subcutaneous tumors was low (Fig. 4E, Fig. 6B ), enforced expression of Ebf3 in medulloblastoma CSCs accelerated the formation of highly malignant subcutaneous tumors (Fig. 6C and D) . Whereas mock CSC-derived tumors were characterized by sarcomatoid/ myxoid morphology and by the presence of Tuj1-and GFAP-IR cells, Ebf3-transduced CSC-derived tumors were more highly undifferentiated, showed a pleomorphic and malignant appearance, contained perivascular cellular rosettes, and comprised only Tuj1-IR cells. In line with these fi ndings, both the mitotic index as measured by Ki67 staining and the frequency of Sox2-IR cells were signifi cantly higher in Ebf3-transduced CSC-derived tumors than in mock CSC-derived tumors (Fig. 6E) . Overall, subcutaneous mock CSC-derived tumors were reminiscent of classic medulloblastomas, and Ebf3 overexpressing tumors resembled highly malignant PNET-like anaplastic medulloblastomas.
To inhibit Ebf3 endogenous expression in medulloblastoma CSCs by RNA interference (RNAi), given that Ebf family members function as active heterodimers, we took advantage of a GFP-coding retroviral construct that allows the concomitant expression of siRNAs against Ebf1-, Ebf2-, and Ebf3 (19) . Signifi cant downregulation of Ebf2 and Ebf3 transcript and protein was observed in Ebf-silenced medulloblastoma CSCs (Fig. 6F) . Mock-and Ebf-silenced medulloblastoma CSCs were then injected subcutaneously. Ebf-silenced tumors were signifi cantly smaller than those generated by mock-transduced cells and, again, this defect was refl ected in the histologic appearance of tumors (Fig. 6G) . In fact, whereas mock CSC-derived tumors showed the typical sarcomatoid/myxoid morphology, tumors in which Ebfs were silenced were characterized by a homogeneous, well-differentiated morphology and reduced proliferation, with cells displaying large and eosinophil cytoplasm, suggestive of a less malignant phenotype.
DISCUSSION
To identify novel molecular targets involved in medulloblastomagenesis to be exploited for selective and effective therapies, we took advantage of the biologic relationship existing between medulloblastoma and the cell progenitor lineages from which it is thought to arise. In fact, different clinical/molecular medulloblastoma subtypes are believed to originate from mutations occurring in distinct stem/precursor cells located in cerebellar germinative regions, such as the rhombic lip derivative and the ventricular zone matrix (20) , as well as in extracerebellar domains, as the dorsal brainstem (3), some of them persisting postnatally (2).
NSCs Can Be Isolated from Extracerebellar Anatomic Sites as the IV Ventricle and Share Functional and Molecular Features with Cerebellar NSCs
During embryonic development, 2 primary cerebellar neurogenic epithelia, that is, the rhombic lip and the IVv ventricular zone, segregate as early as embryonic day 9 (E9) and represent the birthplace of all GABAergic and glutamatergic lineages, respectively (1, 21) . Early postnatally, the rhombic lip derivative located at the cerebellar surface, the EGL, undergoes a massive expansion due to GCP proliferation that peaks at P7 and gradually ceases, being completely exhausted within the third postnatal week in rodents and the fi rst year in humans (22) . Very recently, a second postnatal cerebellar neurogenic compartment has been identifi ed within the cerebellar white matter (4, 5) . Cerebellum white matter NSCs were shown to self-renew shortly in culture and to be multipotent in vitro and in vivo (4) . We also generated P7 cerebellum white matter neurospheres, which were subcultured for many passages, giving rise to long-term expanding NSCs (6) . Most interestingly, by applying the same culture conditions to cells obtained from the P7 brain parenchyma surrounding the IVv, from which short-term proliferating precursors were previously isolated (7, 8) , we established longterm self-renewing multipotent bona fi de IVv NSCs.
As previously shown for embryonic NSCs (23), the distinct postnatal NSC populations did maintain their original positional identity. In fact, both cerebellum and IVv NSCs overexpressed transcription factors, such as Pax3 and En2, which are well-known regulators of hindbrain development. Likewise, subventricular zone NSCs displayed enhanced expression of genes involved in forebrain development, for example, Emx2, Foxg1, and Lhx2. Most interestingly, IVv NSCs, which were isolated from an extracerebellar region, were molecularly indistinguishable from cerebellum white matter NSCs, thus suggesting that progenitors residing in different anatomic sites might have a common origin. Relevantly, when challenged oncogenically, hindbrain-derived postnatal NSCs generate medulloblastoma/ PNET-like lesions, suggesting that multiple populations of hindbrain NSCs may be at the origin of medulloblastoma (3). Accordingly, IVv NSCs could be isolated not only from early postnatal mice but also from adults, in line with the observation that medulloblastomas deriving from brainstem progenitors show a distributed age of onset, ranging from late infancy to adulthood, with a peak in older children (24) .
Molecular Analysis of Medulloblastoma-Derived CSCs and Hindbrain-Derived NSCs Identifi es Novel Potential Molecular Mediators of Medulloblastomagenesis
In agreement with previous observations in medulloblastoma cell cultures and serum-cultured colon cancer cells (25, 26) , the expression of downstream mediators of Shh pathway in NSCs and medulloblastoma CSCs was modest, and, accordingly, Shh pathway activation was marginally relevant for proliferation and self-renewal of NSC/CSCs (27) as well as in CSCs isolated from the same Ptch mouse model (28) or other brain tumors (29) . Indeed, both NSC/CSC-derived neurospheres employed in those studies were maintained in vitro for very few subculturing passages. Short-term NSC/CSC cultures are mostly composed by committed progenitors (30) . As such, lineagerestricted precursors, rather than NSC/CSCs might have been addicted to Shh signaling and, therefore, responded to Shh inhibition by reduced survival and proliferation. On the contrary, long-term propagated cultures, which are highly enriched in the NSC/CSC component and devoid of committed precursors (30), might not be Shh dependent and may self-maintain through different signaling pathways. Alternatively, chronic exposure of NSC/CSCs to mitogenic stimulation, in particular to FGF2 (31), might repress Shh pathway activation and promote the activity of different compensatory effectors.
Notably, although Shh pathway activation was not retrieved in postnatal NSCs, the cerebellum/IVv NSC gene signature is signifi cantly associated with the Shh human molecular subgroup. This observation might imply cerebellum white matter and IVv NSCs as additional cells of origin for medulloblastomas, as they share the expression of the Shh pathway mediators with EGL GCPs, which are well known to be causatively involved in medulloblastoma tumorigenesis (32, 33) .
Most relevantly, the genes characterizing Ptch +/− p53 +/+ medulloblastoma CSCs were associated with the Shh molecular subgroup of human medulloblastomas, whereas those overexpressed in Ptch +/− p53 −/− medulloblastoma CSCs were enriched in the WNT subgroup, thus emphasizing the exploitability of these medulloblastoma CSCs as in vitro preclinical model of Shh-and Wnt-dependent medulloblastomas, respectively. Moreover, the observation that the site of transplantation of medulloblastoma CSCs under experimental in vivo settings results in tumors endowed with varying degree of malignancy, ranging from well-differentiated desmoplastic intracranial tumors to highly undifferentiated anaplastic subcutaneous tumors, further underline the relevance of medulloblastoma CSCs as a versatile model, highly representative of the different variants of human medulloblastomas.
In line with a recent report (9), we established long-term self-renewing CSC lines from medulloblastomas, which spontaneously develop in Ptch heterozygous mice (34) and in compound Ptch/p53 mutants (10) . However, only medulloblastoma CSCs, characterized by genetic or somatic p53 loss, were able to generate fully developed tumors closely mimicking the different histologic variants of the human disease. Interestingly, the gene signature distinguishing Ptch +/− p53 −/− medulloblastoma CSCs is enriched in the WNT subgroup, in agreement with the recent fi nding that, in medulloblastoma patients, p53 mutations are mostly found in favorable-risk WNT-subtype medulloblastomas (35) .
Reactivation of Developmentally Regulated Proneural Molecular Programs Favors Medulloblastomagenesis
During development, Ebf transcription factors are selectively expressed in early postmitotic neurons (36) . However, we observed that Ebf3 expression was retrieved not only in postmitotic GCPs of the inner EGL but also in bromodeoxyuridine (BrdUrd)-incorporating GCPs undergoing neuronal fate choice in the outer EGL. Accordingly, enforced expression of Ebf3 in NSCs and medulloblastoma CSCs did not induce cell-cycle arrest or apoptosis, but, rather, premature and enhanced neuronal commitment, which was already evident under proliferative conditions and was maintained upon differentiation.
Most interestingly, enforced expression of Ebf3 in medulloblastoma CSCs greatly increased their tumorigenic ability, indicating that the Ebf3-mediated induction of a neuronal phenotype in medulloblastoma cells might be required to promote medulloblastoma initiation and progression, in agreement with recent reports proposing that the acquisition of granule cell neuronal commitment is essential for medulloblastomagenesis (32, 33) . Of note, the molecular subgroup of human medulloblastomas showing a highly malignant behavior is associated with a neuronal signature (24) .
Ebf3 expression is known to be undetectable in many human cancers, including leukemias, pancreatic cancers, head and neck squamous cell carcinomas and, most interestingly, GBMs. In many of these cancers, EBF3 inactivation is due to epigenetic silencing by promoter methylation, genomic deletion, or point mutations. As expected, Ebf 3 expression in these tumor cells induces cell-cycle arrest and apoptosis, indicating that Ebf3 could act as tumor suppressor (37) . By contrast, our fi ndings suggest that Ebf3 expression in malignancies belonging to the neuronal lineage, such as medulloblastomas and, possibly, neuroblastomas, might play a pro-oncogenic role, in contrast with glial tumors and other cancers.
Transcriptional data derived from molecular comparisons between normal NSCs and medulloblastoma CSCs thus holds great potential as preclinical molecular tools for the identifi cation of novel molecular determinants and meaningful gene signatures in medulloblastoma.
METHODS
Isolation of NSCs and CSCs
NSC cultures were established from the subventricular zone, the cerebellum, and the region surrounding the IVv of P7 mice, whereas CSCs were obtained from tumors developed in 3-to 6-months-old animals. NSC lines were established from tissues pooled from 4 to 6 mice, whereas CSC lines were from single tumors. NSC and CSC lines were cultured and propagated in standard medium as described by Galli and colleagues (38) .
Differentiation of NSCs and CSCs
NSCs and CSCs were differentiated by withdrawal of mitogens from the culture medium and addition of 2% FBS for 7 days (38) 
